Hi @babytiger , There's many factors at play here, however one of the main reasons is that insinuations have taken profits and now there's heavy shortening happening. See the the below volume been shorted on A2M. Institution never lose money, they make money on the way up and on the way down. Also, the next reporting period for A2M is in December, which is quiet long time for a stock to continue in an up trend. Don't get me wrong, there's time a trend can be up/down for months or even years. Maybe the management have something up their sleeves and burn all the shorts with an announcement? Fundamentally a brilliant company, undervalue, and nothing has changed. It's going sideways for now until it create a new support zone. As long term holder i'm still waiting for my final confirmation before i buy more.
@asb83, how on earth did you come with your conclusion that A2M is fairly evaluated? You're incorrect in say that. The stock is undervalued as it is.
- Forums
- ASX - By Stock
- A2M
- Chart Update
Chart Update, page-7394
-
- There are more pages in this discussion • 17,837 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.85 |
Change
-0.030(0.44%) |
Mkt cap ! $4.952B |
Open | High | Low | Value | Volume |
$6.93 | $6.98 | $6.83 | $10.27M | 1.490M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 18844 | $6.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.85 | 41602 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 11039 | 6.840 |
1 | 3000 | 6.830 |
4 | 17920 | 6.820 |
4 | 9541 | 6.810 |
2 | 5020 | 6.800 |
Price($) | Vol. | No. |
---|---|---|
6.850 | 41602 | 1 |
6.860 | 548 | 1 |
6.870 | 8050 | 3 |
6.880 | 16820 | 3 |
6.890 | 5115 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online